logologo
  • Home
  • About Us
  • Products
  • News
  • Service
  • Contact Us
中文
MedicalSystem Shines at WHX Bangkok 2026!
News
2026/7/11
July 8–10, 2026 | Bangkok, Thailand — MedicalSystem made a standout appearance at WHX Bangkok 2026, held at the Queen Sirikit National Convention Center (QSNCC). Showcasing its full-spectrum smart laboratory solutions and innovative precision diagnostics portfolio, the company engaged deeply with hospitals, third-party laboratories and premium clinical institutions across Southeast Asia, accelerating its ASEAN market expansion through locally tailored products and established service capabilities.

1. Comprehensive Diagnostic Portfolio Tailored to ASEAN Clinical Needs

MedicalSystem presented its biochemistry, immunoassay and hematology lines, engineered for both routine screening and specialized diagnostics. Designed for ease of operation, robust stability and low maintenance cost — ideally suited to tropical climates — the portfolio addresses diverse clinical demands from health screening and chronic disease management to emergency rapid testing.
The booth drew sustained traffic from distributors and procurement representatives across Thailand, Malaysia, Indonesia, Vietnam and India. Through one-on-one consultations covering product advantages, localized partnership models and after-sales support, the team secured multiple regional distribution and project cooperation intentions, strengthening its foothold in the market.

2. 2026 Bangkok Gala: Strategic Partners Convene for Shared Growth

On the afternoon of July 8, MedicalSystem hosted its 2026 Gala and Promotion Event | Bangkok under the theme "Intelligence for Diagnostics, Win-win with partners", bringing together key strategic partners, leading distributors and industry experts for an exclusive networking and knowledge-sharing session.
Mr. Zou Bingde, Chairman of MedicalSystem, delivered the opening address, outlining the company's long-term globalization strategy for Southeast Asia and reaffirming its commitment to growing alongside regional partners. Product Manager Chen followed with an in-depth presentation on core technological differentiators, delivering insights of both technical depth and practical value.
The agenda further covered market-specific product solutions, channel development strategies and technical training frameworks — underscoring MedicalSystem's resolve and end-to-end service capabilities in overseas markets. Attendees expressed strong confidence in both the ASEAN healthcare outlook and deepened collaboration with MedicalSystem.

3. Deepening ASEAN Footprint, Co-Engineering the Future of Regional Healthcare

Southeast Asia stands as one of the world's fastest-growing healthcare markets, with rising demand for infrastructure upgrade, precision diagnosis and primary care enhancement — making it a strategic pillar of MedicalSystem's global expansion.
Building on the Bangkok exhibition and partner summit, MedicalSystem further solidifies its ASEAN presence through proprietary innovation, a diversified product portfolio and localized service infrastructure. Going forward, the company will continue refining region-specific diagnostic solutions, optimizing channel networks, and strengthening local after-sales and technical training — delivering high-quality, highly adaptable diagnostic products and services to advance healthcare standards across Southeast Asia and extend the global reach of Chinese innovation.
logo
Products
Chemiluminescence
Biochemistry
Integrated Combination
TLA System
Hematology
Mass Spectrometry
Blood Lipid Subfraction Analysis
Service
Service Support
Resource Center
About Us
Company Profile
Core Values
Milestone
Quality & Compliance
Qualification
Contact Us
Office Address: No. 289, Qiming South Road, Yinzhou District, Ningbo, 315104 Zhejiang, P.R. China
Tel: +86-574-55337009
Fax: +86-574-88231889
Email: sales@nbmedicalsystem.com
Web Site: https://en.nbmedicalsystem.com/
Copyright 2003 - 2026 Medicalsystem Biotechnology Co., Ltd.ZHE ICP Bei No.09005791 - 14